Safety measures for COVID-19: a review of surgical preparedness at four major medical centres in Saudi Arabia

Alsofyani, Mohammad A; Malaekah, Haifaa; Bashawyah, Ahmed; Bawazeer, Mohammed; Akkour, Khalid; Alsalmi, Sultan; Alkhairy, Abdu; Dajim, Nayef Bin; Khalifah, SalahAddeen O.; Almalki, Ibrahim A.; Kassab, Farid; Barnawi, Mohammad; Almalki, Mosfer; Al‐Harthi, Mohammed A.; Alharthi, Majed; Almalki, Abdulaziz; Almalki, Abdullah; Bourghli, Anouar; Obeid, Ibrahim

doi:10.1186/s13037-020-00259-1

Cited by 16 publications

(22 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Saudi Arabia, as of 4 November 2021, there were more than 0.5 million confirmed COVID-19 cases, resulting in 8799 deaths [22]. Similar to other countries, the Ministry of Health (MoH) in Saudi Arabia was actively engaged in their efforts to mitigate the COVID-19 pandemic by formulating public health interventions and society-level preventive measures and ensuring compliance with these preventive measures in collaboration with other authorities in Saudi Arabia [23][24][25][26][27]. Consequently, due to the effective strategies adopted in Saudi Arabia, the R 0 decreased substantially [28].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry

et al. 2022

View full text Add to dashboard Cite

Patients with diabetes have a higher risk of severe infection and mortality due to COVID-19. Considering the current limited effective pharmacological treatments, vaccination remains one of the most effective means to control the pandemic. The current study aimed to determine the prevalence of COVID-19 infection and the rate of COVID-19 vaccination coverage among patients with type 2 diabetes mellitus. The patients were identified from a diabetes hospital registry at Prince Sultan Military Medical City, Riyadh, Saudi Arabia in July 2021. The history of COVID-19 infection and the vaccination status were retrieved from the National Health Electronic Surveillance Network (HESN) program and the Seha platform, respectively. A total of 11,573 patients were included in this study (representing 99.5% of all patients in the registry). A total of 1981 patients (17.1%) had a history of confirmed COVID-19 infection. The rate of vaccination with a 1st dose was 84.8% (n = 9811), while the rate of full vaccination with the 2nd dose was 55.5% (n = 6422). The analysis showed that a higher proportion of male patients were fully vaccinated than female patients (61.0% versus 51.2%, p < 0.001). There were statistically significant differences among the age groups, with the full vaccination rate ranging from 59.0% for the 61–70-year-old age group to 49.0% for the > 80-year-old age group (p < 0.001). The patients with no previous history of COVID-19 infection were more likely to get fully vaccinated than those with a previous history of the infection (63.9% versus 14.6%, respectively, p < 0.001). The factors associated with a higher likelihood of unvaccinated status included the female gender (adjusted odds ratio (aOR) = 1.705 (95% confidence interval (CI): 1.528–1.902)), elderly patients in the age group of 61–70 (aOR (95% CI) = 1.390 (1.102–1.753)), the age group of 71–80 (aOR (95% CI) = 1.924 (1.499–2.470)) and the age group of >80 (aOR (95% CI) = 3.081 (2.252–4.214), and prior history of COVID-19 infection (aOR (95% CI) = 2.501 (2.223–2.813)). In conclusion, a considerable proportion of patients with type 2 diabetes had confirmed COVID-19 infection. Continued targeted efforts are needed to accelerate vaccination coverage rates among patients with diabetes in general and the particular subgroups identified in this study.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The first case reported in the country on March 2nd, 2020. [6] Extensive efforts by the Ministry of health in Saudi Arabia were done to combat the spread of diseases in healthcare facilities [7]. These efforts help to control the transmission of the disease, reduce complications and mortality among infected cases.…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Risk Factors of Burnout among Healthcare Professionals during COVID-19 Pandemic - Saudi Arabia

Alanazi¹,

Saleh²,

Al-Eidi³

et al. 2020

AJPHR

View full text Add to dashboard Cite

Objective: study the impact of COVID-19 pandemic on the prevalence of burnout and the associated factors among health care workers in Saudi Arabia. Methodology: This study targeted all categories of health care workers (HCWs) in Saudi Arabia. The data were collected through an online questionnaire that included: sociodemographic data, medical history, smoking history, work characteristics, direct care of infected patients, questions of Maslach Burnout inventory (MBI) to assess burnout among health care workers that assess the Emotional Exhaustion (EE), Depersonalization (DP), and Personal Achievement (PA). The collected data was analyzed through SPSS program version 25. Results: The total number of the participants in this study was 3,557. The results showed that 38.5% of the participants scored high for EE, 31.2% for DP, and 33.6% for PA. On analysis, being younger than the age of 40 years, female, or Saudi nationality tended to be associated with increased all burnout parameters. Shift work, on call duties, changing working hours, direct involvement in management of COVID-19 patients were associated with high burnout scores. Conclusion: High burnout is common among healthcare workers in Saudi Arabia during COVID-19 pandemic due to direct contact with infected cases and changes in the working patterns during the pandemic, etc. These factors should be discussed to find solutions to relieve the health care workers from excess stress and burnout.

show abstract

“…The priority of admissions is urgency, but most cases are being admitted. [ 16 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ] USA Some hospitals have taken early precautions to avoid the spread of COVID-19, which was done by regulating the admissions; some of the hospitals discriminated between admissions for COVID-19 positive and COVID-19 negative glioma cases. Admissions were mostly including urgent fatal glioma cases.…”

Section: Discussionmentioning

confidence: 99%

Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review

Azab

Azzam

2021

Brain Disorders

View full text Add to dashboard Cite

Background The coronavirus pandemic has affected many health care services worldwide since the emergence of the first case in Wuhan. Surgical neuro-oncology care is a fundamental part of hospital services, making it susceptible to strategic changes amid the COVID-19 pandemic. Methods An electronic search on several databases (PubMed/Medline, Scopus, and Google Scholar) from the beginning of the pandemic to the end of 2020, each paper was reviewed independently. The publication inclusion and exclusion criteria were done using Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. Results Eight studies were found to be eligible for our meta-analysis. Most of the studies were on a retrospective basis, except one which was retrospective and prospective. An overall of 951 glioma patients’ were included for surgical admission from the beginning of the pandemic until 2020. Seventy-four patients' had mortality outcomes, and 250 patients had complications for both surgical admitted and non-surgical admitted purposes. Conclusions To our knowledge, we made the first systematic review and meta-analysis regarding the management of glioma patients’ during the pandemic of COVID-19. Our main findings are that the number of surgical admissions for glioma patients’ did not significantly differ between COVID-19 negative and COVD-19 positive cases; however, surprisingly, we found that both overall complications and mortality outcomes were more significant COVID-19 negative patients’ from the reported studies.

show abstract

Safety measures for COVID-19: a review of surgical preparedness at four major medical centres in Saudi Arabia

Cited by 16 publications

References 30 publications

Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry

Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry

Prevalence and Risk Factors of Burnout among Healthcare Professionals during COVID-19 Pandemic - Saudi Arabia

Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review

Contact Info

Product

Resources

About